Cargando…
Protein Phosphatases—A Touchy Enemy in the Battle Against Glioblastomas: A Review
Glioblastoma (GBM) is the most common malignant tumor arising from brain parenchyma. Although many efforts have been made to develop therapies for GBM, the prognosis still remains poor, mainly because of the difficulty in total resection of the tumor mass from brain tissue and the resistance of the...
Autores principales: | Tomiyama, Arata, Kobayashi, Tatsuya, Mori, Kentaro, Ichimura, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406705/ https://www.ncbi.nlm.nih.gov/pubmed/30791455 http://dx.doi.org/10.3390/cancers11020241 |
Ejemplares similares
-
ET-09 ACQUIRED MALIGNANT BEHAVIORS OF NPE6-PDT-SURVIVED GLIOBLASTOMA CELLS ARE SUPPRESSED BY USING MEK1/2 INHIBITOR TRAMETINIB
por: Kobayashi, Tatsuya, et al.
Publicado: (2019) -
Mast cells get all touchy-feely
por: Leslie, Mitch
Publicado: (2015) -
SPDR-06 PROTEIN DEUBIQUITINATION PATHWAY IS A NOVEL THERAPEUTIC TARGET AGAINST MALIGNANT CNS NON-GERMINOMATOUS GERM CELL TUMORS
por: Tomiyama, Arata, et al.
Publicado: (2019) -
Man and His Enemies: The Wager of Battle
Publicado: (1889) -
ET-05 Alectinib and ceritinib, the second-generation ALK inhibitors, effectively induce glioblastoma cell death
por: Kawauchi, Daisuke, et al.
Publicado: (2020)